DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
PEGULICIANINE ACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PEGULICIANINE ACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
F3F6208UMT
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEP-5214
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor inhibitor
CEP-5214
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H28N2O3
Molecular Weight:
440.54
AlogP:
4.92
PSA:
63.49
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LUMRETUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
LUMRETUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
Y6M3205516
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEDISERTIB
1
Small molecule
Investigational
Unknown
Unknown
Gliosarcoma; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Neoplasms; Neuroendocrine Tumors; Prostatic Neoplasms; Rectal Neoplasms; Small Cell Lung Carcinoma
Unknown
NEDISERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
GN429E725A
Molecule Type:
Small molecule
Molecular Formula:
C24H21ClFN5O3
Molecular Weight:
481.92
AlogP:
3.81
PSA:
93.49
HBD:
1.0
HBA:
#RotB:
5.0
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
RG6029
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG6029
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LXS-196
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LXS-196
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
ORVACABTAGENE AUTOLEUCEL
1
Gene
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
ORVACABTAGENE AUTOLEUCEL
×
Maximum Phase:
1
First Approval:
None
UNII:
K8RW1TW3EM
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CMD-193
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Lewis Y antigen binding agent
CMD-193
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-8055
1
Small molecule
Investigational
Unknown
Unknown
Astrocytoma; Carcinoma, Hepatocellular; Glioblastoma; Lymphoma; Neoplasms; Oligodendroglioma
Serine/threonine-protein kinase mTOR inhibitor
AZD-8055
×
Maximum Phase:
1
First Approval:
None
UNII:
970JJ37FPW
Molecule Type:
Small molecule
Molecular Formula:
C25H31N5O4
Molecular Weight:
465.55
AlogP:
2.64
PSA:
93.07
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CE-245677
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase TIE-2 inhibitor
CE-245677
×
Maximum Phase:
1
First Approval:
None
UNII:
GMH17J9LHL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
DTP-348
1
Small molecule
Investigational
Unknown
Unknown
Head and Neck Neoplasms
Unknown
DTP-348
×
Maximum Phase:
1
First Approval:
None
UNII:
2HB46A9CNM
Molecule Type:
Small molecule
Molecular Formula:
C6H11N5O4S
Molecular Weight:
249.25
AlogP:
-1.11
PSA:
133.15
HBD:
2.0
HBA:
#RotB:
5.0
Source:
IBI-939
1
Unknown
Investigational
Unknown
Unknown
Lung Neoplasms; Neoplasms
T-cell immunoreceptor with Ig and ITIM domains inhibitor
IBI-939
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
WP 1066
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
WP 1066
×
Maximum Phase:
1
First Approval:
None
UNII:
63V8AIE65T
Molecule Type:
Small molecule
Molecular Formula:
C17H14BrN3O
Molecular Weight:
356.22
AlogP:
3.63
PSA:
65.78
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AVID200
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AVID200
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELGEMTUMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
ELGEMTUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
5F1CN52GFM
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
5-METHYL-2'-FLUOROARAURACIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
5-METHYL-2'-FLUOROARAURACIL
×
Maximum Phase:
1
First Approval:
None
UNII:
37F7D05ANB
Molecule Type:
Small molecule
Molecular Formula:
C10H13FN2O5
Molecular Weight:
260.22
AlogP:
-1.57
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
TAVOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
TAVOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
4LU9B48U4D
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COMBRETASTATIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
COMBRETASTATIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7O62J06F18
Molecule Type:
Small molecule
Molecular Formula:
C18H22O6
Molecular Weight:
334.37
AlogP:
2.7
PSA:
77.38
HBD:
2.0
HBA:
#RotB:
7.0
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
EPZ-5676
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPZ-5676
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04995274
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Depressive Disorder, Treatment-Resistant
Unknown
PF-04995274
×
Maximum Phase:
1
First Approval:
None
UNII:
XI179PG9LV
Molecule Type:
Small molecule
Molecular Formula:
C23H32N2O6
Molecular Weight:
432.52
AlogP:
2.63
PSA:
86.42
HBD:
1.0
HBA:
#RotB:
7.0
Source:
LY3415244
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY3415244
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEMOTRIZINOL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BEMOTRIZINOL
×
Maximum Phase:
1
First Approval:
None
UNII:
PWZ1720CBH
Molecule Type:
Small molecule
Molecular Formula:
C38H49N3O5
Molecular Weight:
627.83
AlogP:
9.48
PSA:
106.82
HBD:
2.0
HBA:
#RotB:
18.0
Source:
BTA-9881
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
BTA-9881
×
Maximum Phase:
1
First Approval:
None
UNII:
9VR1J6U4XG
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClN4O2
Molecular Weight:
390.83
AlogP:
2.94
PSA:
66.4
HBD:
0.0
HBA:
#RotB:
2.0
Source:
1
2
…
93
94
95
96
97
98
99
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA